Skip to content
Study details
Enrolling now

Smart Walk Trial

Arizona State University
NCT IDNCT06337708ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

240

Study length

about 4 years

Ages

24–65

Sex

Female only

Locations

1 site in AZ

What this study is about

This trial is testing a smartphone-delivered program to help African American women increase physical activity. The goal is to reduce the risk of heart disease and type 2 diabetes. This intervention uses a Fitbit device.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Fitbit
  • 2.Participate in Smart Walk

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Change in aortic pulse wave velocity from baseline to 4- and 12-months, Change in blood pressure (mmHG) from baseline to 4- and 12-months, Change in body mass index from baseline to 4- and 12-months, Change in body weight from baseline to 4- and 12-months., Change in cardiorespiratory fitness from baseline to 4- and 12-months, Change in exercise self-efficacy from baseline to 4- and 12-months, Change in interleukin 6 (IL-6) from baseline to 4- and 12-months

Devices

wearable

Body systems

Endocrinology